SER

Serina Therapeutics, Inc.

$2.00 -0.17 (-7.83%) At close · Jul 8

Market Cap

$30.00M

14,997,505

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date	Headline
2026-05-22	Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi
2026-05-14	Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
2026-04-08	Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
2026-04-07	Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit
2026-04-02	Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan
2026-03-25	Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
2026-03-24	Serina Therapeutics to Present at the 38th Annual Roth Conference
2026-03-18	Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson’s Disease
2026-02-24	Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
2026-02-19	Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease

Past events

Date	Event	Type
2025-04-09	Jones Healthcare and Technology Innovation Conference	Conference
2025-04-09	Jones Healthcare and Technology Innovation Conference	Conference

Source: https://investors.serinatx.com/overview/default.aspx

Key facts CIK 1708599 CUSIP 81751A108 Visit website Investor relations